RxDoctor Payments Data

Ann Kim, MD

Physical Medicine & Rehabilitation · Newark, DENPI 1568575884

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Abbott at 39.1% of the total. Reporting peaked in 2024 at $209 and has fallen 64.7% since, to $74 in 2025.

$710in general payments, 2019–2025

Across 24 payments — averaging $29.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$278
  • Philips North America LLC$125
  • Medtronic$97
  • Boston Scientific$85
  • Scilex Pharmaceuticals Inc.$37
  • Relievant Medsystems, Inc.$34
  • plus $54 from 3 others

What the payments were for

  • Food & beverage$710100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$710 in reported general payments places this provider in the 65th percentile of 32 physical medicine & rehabilitation providers in Delaware.

See all physical medicine & rehabilitation providers in Delaware

Medicare billing

Part B allowed, 2024
$208,192
Medicare patients
463
Services billed
7,676

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin350$4,807
Duloxetine Hcl104$3,714
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen146$3,408
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen133$2,972
Tizanidine Hcl174$2,099
Celecoxib39$2,020
Pregabalin75$1,878
Tramadol Hcl ErTramadol Hcl11$789
Diclofenac Sodium21$611
Acetaminophen-CodeineAcetaminophen With Codeine52$584
Tramadol Hcl86$557
Baclofen40$512
Morphine Sulfate ErMorphine Sulfate12$387
Oxycodone Hcl22$376
Methylprednisolone54$357

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →